Please login to the form below
Novo-Nordisk
This page shows the latest Novo-Nordisk news and features for those working in and with pharma, biotech and healthcare.
Trust – years to build, seconds to break and forever to repair
We are also seeing some very unique partnerships, such as Novo Nordisk and Carlsberg working together to produce hand sanitiser for the Danish market.
Latest news
-
The best work in healthcare communications shines at virtual Communiqué Awards
5.Excellence in Professional Education Programmes. Sponsored by earthware. Winner: Academy for Science and Continuing Medical Education in Diabetes (ASCEND) by International Medical Press (a part of Nucleus Global) for Novo ... Winner: It’s More than
-
Novo Nordisk hits pause on rival to Hemlibra for haemophilia
Halts three studies because of safety concerns. The clinical trials of concizumab, an antibody-based treatment for haemophilia A and B in development at Novo Nordisk, have been put on hold ... Novo Nordisk said it had decided to suspend the trials as a
-
Lilly joins new Medicare scheme to reduce insulin prices
Lilly, along with other insulin manufacturers including Sanofi and Novo Nordisk, have been cutting the price of their products in response to increasing public pressure over the increase in costs for
-
Lilly’s Trulicity scores CV reduction indication in the US
The new MACE approval could help Lilly in its fight for market share with other GLP-1 agonists, including Novo Nordisk’s once-weekly drug Ozempic (semaglutide). ... Novo also has Rybelsus – oral semaglutide – in its arsenal, and analysts at Pareto
-
New drugs drive Novo Nordisk despite insulin price pressures
Novo Nordisk has revealed its fourth quarter report, posting a surprise increase in sales for the quarter but forecasted pricing pressure on its insulin products could hurt overall growth this year. . ... Operations and Region Europe,” said Novo’s
More from news
Approximately 145 fully matching, plus 285 partially matching documents found.
Latest Intelligence
-
Mapping the patient journey and minding the gap
UCB has reconfigured its teams around Patient Value Units. Novo Nordisk has established Disease Experience Expert Panels (DEEP), an approach based on ‘an evolving world view where people with serious chronic
-
Novo Nordisk awakens its ‘Sleeping Beauty’
Novo Nordisk’s Biopharm is showing solid growth after a stuttering start, and its new leader believes a ‘sleeping beauty’ has been awoken. ... The small revolution we are also running in Novo Nordisk is to realise that we have many platforms at our
-
Darwinian leadership in the life sciences industry
I interviewed 23 CEOs and other executives from companies as varied as Novo Nordisk and Novartis to Smith &Nephew and B.Braun. ... And as Novo Nordisk’s Lars Fruergaard Jørgensen eloquently put it, at the overlap of health, science and business, there
-
Pharma industry consensus: fix data strategy before pushing artificial intelligence and machine learning applications
The old way of working will just not help.”. Thomas Thestrup-Terp, Vice President, Commercial Operations, Novo Nordisk, agrees unequivocally that organisations lack the good clean commercial data they need before
-
The fight for affordable insulin
The world’s three biggest insulin manufacturers are Novo Nordisk, Sanofi and Eli Lilly. ... Elizabeth takes issues with many of Lilly’s access claims (and those of Sanofi and Novo Nordisk), which don’t tally with the experience of her
More from intelligence
Approximately 6 fully matching, plus 38 partially matching documents found.
Latest appointments
-
New hires at Nanoform, Leo Pharma and Calliditas
He has previously worked in various positions at Novo Nordisk, most recently as its Senior Global Regulatory Lead. ... During his time at Novo Nordisk, he led the strategic regulatory input for the orphan drug NovoEight from phase 1 through phase 3.
-
Ashfield, Health Unlimited and Ashley Communications add to their teams
The latest med comms movers. Ashfield appoints Novo’s sales and marketing director. ... Van Weperen was most recently at diabetes giant Novo Nordisk, where he worked on delivering insulin and GLP1 biosimilar defence strategies, leading Novo’s UK
-
Healthcare Comms appointments
Thomas has previously held senior positions at Novo Nordisk including head of sales North, UK.
-
Lars Rebien Sørensen becomes chairman of Novo Holdings
He will take up the new role 1 July. Former Novo Nordisk CEO Lars Rebien Sørensen has been appointed as Novo Holdings’ new chairman. ... years. Sørensen will succeed Sten Scheibye - who retires effective 1 July - and he will also become chairman of
-
Novo Nordisk appoints new general manager
He said: “I am delighted to join Novo Nordisk in the role of general manager in the UK. ... The vision, values and passion that is immediately evident within the company makes Novo Nordisk and exciting organisation to be a part of.
More from appointments
Approximately 10 fully matching, plus 36 partially matching documents found.
Latest from PMHub
-
After a busy first quarter, emotive welcomes five new team members
She also holds a level 5 CIPD in HR management achieved during her time at Novo Nordisk. .
-
Attigo (part of the Mednet Group)
Johnson and Johnson. University of Leeds. Lundbeck Mind. MSD. Novo. Nordisk.
-
Havas Lynx Group
Grϋnenthal. Janssen. Lilly. Lundbeck. Merck Serono. Novartis. Novo Nordisk. Pfizer. Roche.
-
Viseven is a Salesforce Consulting Partner
Join the upcoming webinar on Salesforce.com expertise in omnichannel pharmaceutical communications to hear a practical case from Novo Nordisk in a powerful, insight-driven session – on Wednesday, May 13,
-
Addressing Climate Impact: The Healthcare Paradox
For the healthcare and pharmaceutical industry, the impact of climate change is twofold – responding to the increased risk of certain diseases and conditions and decarbonising their own processes and products to prevent worsening impact. Andrew
More from PMHub
Approximately 2 fully matching, plus 43 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Gilead agrees $21bn buyout of Immunomedics
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- Gavi says 76 wealthy countries have committed to COVAX vaccine facility
- Roche’s Ocrevus boasts positive long-term data in MS
- First patients dosed with COVID-19 vaccine from SpyBiotech and Serum Institute of India
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020
- Alone we can do so little, together we can do so much
- What can't we afford to treat anymore?
- OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
PMHub
Health Unlimited
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...
Latest intelligence
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
- 7 important considerations for creating an inclusive clinical trial website
- You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Quick links
Infographics
